HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EWG Will Verify Cosmetic Ingredients So Clean Options Are ‘Easier To Source’

Executive Summary

“EWG Verified” now is open to cosmetic ingredients, and all companies are invited to partake in the NGO’s “Reviewed for Science” program driving collaboration between the its scientists and private-sector counterparts.

You may also be interested in...



US Rep. Schakowsky Wants Cosmetic Supply Chain Transparency; Benzene In Sunscreen Cited

Cosmetic ingredient and raw material suppliers would be required to share toxicity and safety data with brand owners, along with certificates of analysis and contaminant testing reports, under the Cosmetic Supply Chain Transparency Act of 2021. The bill is part of a proposed Safer Beauty package introduced in the US House on 29 July by Jan Schakowsky, D-IL, and colleagues.

Is ‘Skin Deep’ Group Out Of Its Depth? EWG Announces ‘Verified’ Expansion To Cosmetic Ingredients

The Environmental Working Group is probing deeper in the supply chain to enhance its understanding of the cosmetics industry and ingredient safety underpinnings. EWG president Ken Cook and Kali Rauhe, director of cosmetic science, discuss the group’s plans for ingredient verification and greater scientific collaboration with cosmetics companies.

EU Starts On Proposal For Tackling ‘Most Harmful’ Chemicals Under Revised Cosmetics Reg

The European Commission is preparing a legal proposal to revise the Cosmetic Products Regulation in line with Green Deal objectives, including the phasing out of chemicals deemed “most harmful." Cosmetics Europe director-general John Chave discusses the problematic approach, possible impacts, and the bizarre and unintended results it could produce.

Topics

Latest News
UsernamePublicRestriction

Register

RS151494

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel